Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus

As new vaccine technologies and platforms, such as nanoparticles and novel adjuvants, are developed to aid in the establishment of a universal influenza vaccine, studying traditional influenza split/subunit vaccines should not be overlooked. Commercially available vaccines are typically studied in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Myers, Mallory L., Gallagher, John R., Woolfork, De’Marcus D., Stradtmann-Carvalho, Regan K., Maldonado-Puga, Samantha, Bock, Kevin W., Boyoglu-Barnum, Seyhan, Syeda, Hubza, Creanga, Adrian, Alves, Derron A., Kanekiyo, Masaru, Harris, Audray K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561127/
https://www.ncbi.nlm.nih.gov/pubmed/36248851
http://dx.doi.org/10.3389/fimmu.2022.1002286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561127/
https://www.ncbi.nlm.nih.gov/pubmed/36248851
http://dx.doi.org/10.3389/fimmu.2022.1002286

Ejemplares similares